0
Login Wishlist Cart 0

Axiostat L88 Hemostatic Trauma Patch – 100% Chitosan-Based Bleeding Control Solution

Your Price: $44.00
Request a custom quote for bulk orders, agency procurement, or government purchases
SKU: L88
Type: Hemostatic Agent
Vendor: Axiobio
$44.00
PRODUCT INFORMATION

The Axiostat L88 Hemostatic Trauma Patch is a 100% chitosan patch (8 cm × 8 cm) by Axiobio that uses patented Protonated Bioadhesive Technology (PBT®) to achieve rapid hemostasis via charge-based muco-adhesion. USFDA cleared (510(k) K202830), NSN codified (6510-72-057-0464), 5-year shelf life, and active on all sides — it conforms to wound surfaces, stops moderate-to-severe bleeding, and is painlessly removed with saline irrigation. Product code: MIL88/L88.

Key Specifications

Specification Detail
Manufacturer Axio Biosolutions Private Limited (Axiobio), Gujarat, India
Product Code / SKU MIL88 / L88
NSN 6510-72-057-0464
FDA Clearance USFDA 510(k) K202830
Active Ingredient 100% chitosan — Protonated Bioadhesive Technology (PBT®)
Patch Dimensions 8 cm × 8 cm (~3.1 in. × 3.1 in.)
Format Flat patch — active on all sides; can be cut, folded, and stuffed into deep wounds
Sterilization Gamma sterilized; vacuum-sealed camouflage packaging
Shelf Life 5 years; ambient temperature storage
Packaging Box of 10 individually sealed units; rugged camouflage foil
Removal Irrigate with saline/water and gently peel off — painless, non-leachable

Product Overview

Axiostat L88 is a compact, square hemostatic patch (8 cm × 8 cm) based on 100% chitosan — one of the purest chitosan hemostatic products available. The product uses Axiobio's patented PBT® (Protonated Bioadhesive Technology), a charge-based mechanism where protonated chitosan forms a strong muco-adhesive bond with negatively charged blood cells and wound tissue surfaces. When applied to a bleeding wound with pressure until the patch adheres to the wound, PBT® creates a mechanical barrier that stops moderate-to-severe bleeding regardless of the patient's clotting cascade status. The patch is active on all sides — a crucial design feature for deep or three-dimensional wounds where single-sided patches are ineffective.

Axiostat's L88 patch holds USFDA 510(k) clearance (K202830) and has received NSN codification (6510-72-057-0464), reflecting its acceptance for military procurement. The product is deployed by military and special operations forces in over 50 countries and has been proven effective in diverse combat environments. The 5-year shelf life at ambient temperature, rugged vacuum-sealed camouflage packaging, and 8 cm × 8 cm format make it ideal for individual operator kits, vest pouches, and squad-level medical equipment. The patch weighs approximately 35g in its sealed package (160 mm × 140 mm × 10 mm).

Unlike granule-based hemostatics (Celox-A) or gauze-based products (QuikClot, Celox Rapid, ChitoGAUZE), the patch format is particularly effective for surface-accessible wounds where coverage is more important than deep packing — including large surface wounds, lacerations, and axillary or junctional wounds where a conforming pad provides better coverage than a rolled gauze. The patch can be cut, folded, and stuffed into deeper wounds if needed. After hemostasis is achieved, the patch is removed painlessly by irrigating with saline or water and gently peeling. Axiostat leaves no powder or granule residue — completely non-leachable.

How to Apply

  1. Tear open the Axiostat package and remove the patch.
  2. Apply the patch directly to the wound with firm pressure until the patch adheres to the wound surface.
  3. Once applied, do not lift or remove — not even to check hemostasis. Maintain firm pressure.
  4. Apply a field dressing over the Axiostat to secure it in position and prevent contamination.
  5. For gunshot wounds, the patch can be folded and stuffed into the wound cavity.
  6. Transport to definitive care with the patch in place.
  7. To remove: irrigate generously with saline or water and gently peel away. No residue remains.

Comparison: Patch vs. Gauze Formats

The Axiostat L88 patch format is distinct from gauze-based hemostatics like QuikClot Combat Gauze and Celox RAPID. The patch is better suited for surface-accessible wounds requiring coverage and adhesion, while gauze packing is preferred for deep wound tracks. For junctional and truncal wounds accessible to the patch format, Axiostat L88 provides rapid deployment with minimal technique required. For the CoTCCC-recommended primary hemostatic, QuikClot Combat Gauze remains the DoD standard. The Axiostat Z-Fold Gauze (MIL-300) is available for deep-wound packing applications.

See MED-TAC's full hemostatic agents collection, or complete your system with hemorrhage control and IFAK kits.

All products sourced from the actual brand manufacturer or authorized master distributors. CoTCCC recommendation status verified where applicable. Ships from MED-TAC International, Pembroke Pines, FL — clinician-founded, veteran-led, SDVOSB-certified.

SPECS & MEASUREMENTS

Specifications coming soon. Contact us for detailed product information.

CLINICAL RATIONALE

Hemostatic Agents

1. Kaolin-Based Hemostatic Agents

(Examples: Combat Gauze, QuikClot EMS Rolled Gauze)

Clinical Rationale (Kaolin-Based):

Kaolin is an inorganic mineral hemostatic that accelerates the body’s natural clotting cascade by activating Factor XII (Hageman factor).
When applied to a bleeding wound, kaolin initiates the intrinsic coagulation pathway, resulting in rapid fibrin formation and stable clot development without generating heat.
Unlike older zeolite-based dressings, kaolin is completely non-exothermic, making it safe for extended wound packing and tissue contact.
It is a Committee on Tactical Combat Casualty Care (CoTCCC)–recommended dressing proven effective in both battlefield and civilian trauma care.

  • Triggers rapid clotting through Factor XII activation
  • No heat production — safe for direct tissue contact
  • Effective in hypothermic and coagulopathic patients
  • Durable gauze structure supports pressure dressings

2. Chitosan-Based Hemostatic Agents

(Examples: Celox Gauze, ChitoGauze, HemCon)

Clinical Rationale (Chitosan-Based):

Chitosan is a biopolymer derived from chitin, functioning through a positive-charge (cationic) mechanism that attracts negatively charged red blood cells and platelets.
This ionic reaction forms a gel-like clot that is independent of the body’s normal clotting factors, making it highly effective in patients with hypothermia or anticoagulant use.
Chitosan also has bacteriostatic properties that help reduce infection risk in contaminated wounds.
It is ideal for environments where traditional coagulation may be impaired.

  • Functions independently of natural clotting pathways
  • Effective in cold or anticoagulated patients
  • Forms an immediate mechanical seal on irregular wounds
  • Natural, biocompatible, and hypoallergenic

3. Cellulose-Based Hemostatic Agents (WoundClot)

(Examples: WoundClot Cellulose Gauze, WoundClot Battle Gauze)

Clinical Rationale (Cellulose-Based):

WoundClot represents a new generation of biosynthetic cellulose-based hemostats, engineered to form a hydrated, gelatinous matrix upon contact with blood.
This matrix absorbs fluid, stabilizes clot formation, and provides a scaffold for platelet and fibrin bonding.
Unlike other agents, WoundClot maintains its structure for hours, supporting sustained hemostasis under arterial or high-pressure bleeding.
It is completely bio-absorbable and non-allergenic, dissolving naturally within 5–7 days without removal.

  • Rapid gel-matrix formation supports durable clot structure
  • Fully bio-absorbable — no removal required
  • Effective for arterial, venous, and mixed bleeding
  • Allergy-safe, non-animal, and non-mineral composition

Clinical Summary

All hemostatic technologies—Kaolin, Chitosan, and Cellulose—share the goal of rapid external hemorrhage control, the leading preventable cause of trauma death.
Each mechanism is suited to specific medical and operational environments:

  • Kaolin: Dependable, non-exothermic, CoTCCC-recommended standard for general tactical use.
  • Chitosan: Ideal for anticoagulated, cold, or maritime conditions.
  • Cellulose (WoundClot): Advanced, bio-absorbable option for high-pressure or surgical-transition wounds.

Selection should be based on environment, casualty physiology, and evacuation timeline. Each mechanism offers unique advantages that complement modern tactical and civilian trauma protocols.

FREQUENTLY ASKED QUESTIONS

Shopping cart

Your cart is empty.

Return to shop